ASRM Physician Members Warn State Reporting Bills Could Turn Fertility Care Into a Political Target
New article in the New England Journal of Medicine highlights concerns about legislative overreach, IVF access, and patient privacy
July 6, 2026
For Immediate Release
Washington, DC—A new article in the New England Journal of Medicine by physician members of the American Society for Reproductive Medicine (ASRM) warns that a growing wave of state bills framed as fertility clinic “reporting” or “transparency” measures could turn deeply personal medical decisions into political targets.
The article, “Mandated State-Level Surveillance of Assisted Reproductive Technology: An Emerging Threat in the United States,” authored by ASRM members Christopher P. Moutos, M.D., John Y. Phelps, M.D., J.D., L.L.M., and Dean M. Moutos, M.D., examines proposals in Arkansas, Texas, and Oklahoma that would impose new reporting requirements on assisted reproductive technology (ART), including in vitro fertilization (IVF). The authors argue these measures could rewrite established medical definitions, discount the expertise of trained fertility specialists, require reporting on private embryo-related decisions, and lay the groundwork for personhood-based restrictions on IVF.
“Patients deserve fertility care guided by trained medical professionals, evidence-based standards, and their own values, not politicians bypassing medical expertise to reshape reproductive medicine through state law,” said ASRM Chief Advocacy & Policy Officer Sean Tipton. “These bills are framed as transparency, but they risk turning private medical decisions into political targets and making IVF harder to access for the families who need it.”
ASRM has long emphasized that ART is already one of the most highly regulated areas of medicine, subject to federal oversight, state medical boards, professional standards, laboratory accreditation, and clinical reporting systems. Replacing medical standards with politically driven definitions undermines patient care, distorts public understanding, and erodes trust between patients and their physicians.
The article comes as lawmakers, courts, patients, and providers continue to confront the fallout from the Alabama Supreme Court’s 2024 decision in LePage v. Center for Reproductive Medicine, which disrupted fertility care and raised urgent questions about the legal status of embryos created through IVF. ASRM has consistently warned that personhood measures granting legal rights or protections to embryos or other fertilized reproductive tissues could disrupt IVF, limit embryo disposition decisions, and interfere with standard medical practice.
“Fearing restrictions on embryo disposition, patients may transfer their existing embryos or seek care entirely in a state with fewer constraints. Physicians may be forced to offer less effective treatments by minimizing the number of embryos created in an IVF stimulation cycle,” wrote Drs. Moutos and Phelps. “The result will be additional financial, logistic, and emotional burdens for patients trying to build a family in a state where access to women’s reproductive healthcare is already limited.”
Read the full article online here.
For Immediate Release
Washington, DC—A new article in the New England Journal of Medicine by physician members of the American Society for Reproductive Medicine (ASRM) warns that a growing wave of state bills framed as fertility clinic “reporting” or “transparency” measures could turn deeply personal medical decisions into political targets.
The article, “Mandated State-Level Surveillance of Assisted Reproductive Technology: An Emerging Threat in the United States,” authored by ASRM members Christopher P. Moutos, M.D., John Y. Phelps, M.D., J.D., L.L.M., and Dean M. Moutos, M.D., examines proposals in Arkansas, Texas, and Oklahoma that would impose new reporting requirements on assisted reproductive technology (ART), including in vitro fertilization (IVF). The authors argue these measures could rewrite established medical definitions, discount the expertise of trained fertility specialists, require reporting on private embryo-related decisions, and lay the groundwork for personhood-based restrictions on IVF.
“Patients deserve fertility care guided by trained medical professionals, evidence-based standards, and their own values, not politicians bypassing medical expertise to reshape reproductive medicine through state law,” said ASRM Chief Advocacy & Policy Officer Sean Tipton. “These bills are framed as transparency, but they risk turning private medical decisions into political targets and making IVF harder to access for the families who need it.”
ASRM has long emphasized that ART is already one of the most highly regulated areas of medicine, subject to federal oversight, state medical boards, professional standards, laboratory accreditation, and clinical reporting systems. Replacing medical standards with politically driven definitions undermines patient care, distorts public understanding, and erodes trust between patients and their physicians.
The article comes as lawmakers, courts, patients, and providers continue to confront the fallout from the Alabama Supreme Court’s 2024 decision in LePage v. Center for Reproductive Medicine, which disrupted fertility care and raised urgent questions about the legal status of embryos created through IVF. ASRM has consistently warned that personhood measures granting legal rights or protections to embryos or other fertilized reproductive tissues could disrupt IVF, limit embryo disposition decisions, and interfere with standard medical practice.
“Fearing restrictions on embryo disposition, patients may transfer their existing embryos or seek care entirely in a state with fewer constraints. Physicians may be forced to offer less effective treatments by minimizing the number of embryos created in an IVF stimulation cycle,” wrote Drs. Moutos and Phelps. “The result will be additional financial, logistic, and emotional burdens for patients trying to build a family in a state where access to women’s reproductive healthcare is already limited.”
Read the full article online here.
For almost a century, the American Society for Reproductive Medicine (ASRM) has been the global leader in multidisciplinary reproductive medicine research, ethical practice, and education. ASRM impacts reproductive care and science worldwide by creating funding opportunities for advancing reproduction research and discovery, by providing evidence-based education and public health information, and by advocating for reproductive health care professionals and the patients they serve. With members in more than 100 countries, the Society is headquartered in Washington, DC, with additional operations in Birmingham, AL. www.asrm.org
For media inquiries regarding this press release contact:
Sean Tipton
ASRM Chief Advocacy and Policy Officer
E: stipton@asrm.org
Anna Hovey
Advocacy Engagement Specialist
E: ahovey@asrm.org
J. Benjamin Younger Office of Public Affairs
726 7th St. SE
Washington, DC 20003
Tel: (202) 863-2494
Press Releases
Check out these press releases as well
ASRM Physician Members Warn State Reporting Bills Could Turn Fertility Care Into a Political Target
ASRM warns state IVF reporting bills could threaten patient privacy, fertility care, and access by replacing medical expertise with political oversight.
ASRM Center for Policy and Leadership Sponsors Petrie-Flom Center’s Annual Conference on Embryo Law and Ethics at Harvard Law School
ASRM and Harvard Law School convene experts to explore IVF policy, embryo law, personhood, AI-selected embryos, and reproductive ethics after Dobbs.
ASRM Calls for Applications for 2026 INNOVATE Pitch Tank Showcase
Apply for the 2026 ASRM INNOVATE Pitch Tank Showcase to pitch reproductive health innovations, compete for $10,000, and connect with investors.
ASRM Releases First Updated Guidance on Recurrent Pregnancy Loss in Over a Decade
ASRM updates recurrent pregnancy loss guidance with evidence-based evaluation, targeted care, and emotional support during High-Risk Pregnancy Week.The News from ASRM
Latest News
An indispensable news digest for reproductive scientists, clinicians and allied health professionals. The Latest News posts are available to ASRM members in good standing only.
ASRM Press Releases/Bulletins
ASRM Press Releases and Bulletins are published by ASRM's Office of Public Affairs to inform the press and Society members of important recent developments.
Topic Resources
View more on the topic of access to care
ASRM Physician Members Warn State Reporting Bills Could Turn Fertility Care Into a Political Target
ASRM warns state IVF reporting bills could threaten patient privacy, fertility care, and access by replacing medical expertise with political oversight. View the Press Release
Latest Season of ASRM Today Offers a Resource for LGBTQ-Inclusive Reproductive Care
The latest season of ASRM Today focuses on LGBTQ+ family-building, speaking directly to the needs of providers, patients, and the many professionals who support the family-building process. Learn more about the latest season of ASRM Today
IVF in the Military: Expanding Access for Service Members
View ASRM’s June 2026 webinar on military IVF access, fertility coverage advocacy, and expanding care for U.S. service members. View the ASRM Webinar on IVF in the Military
ASRM Responds to Supreme Court Mifepristone Decision
ASRM supports continued access to mifepristone, warning that unnecessary restrictions could delay reproductive healthcare and harm patients. View the Press Release
Journal Club Global (Portuguese): Access to fertility services by transgender and nonbinary persons
ASRM webinar explores transgender and non-binary fertility care, preservation options, gender dysphoria, ethics, and inclusive reproductive healthcare. View the Video
ASRM Responds to Trump Administration’s Announcement Regarding Insurance for Fertility Care
ASRM responds to Trump IVF insurance proposal, urging broader fertility care access and public input on draft coverage rules. View the Press Release
ASRM Center for Policy and Leadership Warns Federal Funding Cuts Are Undermining Reproductive Health Infrastructure
Federal funding cuts to NIH, CDC, and FDA threaten reproductive health research, patient safety, and access to care, warns new ASRM policy report. View the Press Release
The U.S. Federal Government and Reproductive Health
The Impact of Federal Funding Cuts on Patients, Providers, and the Field of Reproductive Medicine. View the Advocacy Resource
Group Spotlight: Access to Care SIG
Access to Care SIG brings together clinicians, researchers, advocates, and industry partners to rethink how care is delivered. Learn more about ATC group.
American Society for Reproductive Medicine Responds to TrumpRx Announcement, Says IVF Access Requires More Than Lower Drug Prices
ASRM has responded to the latest announcement about TrumpRx and its impact on IVF treatments. View the Press Release
ASRM Responds to Speaker Johnson’s Stripping of Fertility Coverage for America’s Military Personnel
ASRM condemns Speaker Johnson’s removal of TRICARE fertility coverage from NDAA, urging action to restore IVF benefits for U.S. military families. View the Press Release
ASRM Inaugural INNOVATE
ASRM INNOVATE spotlighted the energy of innovation in reproductive medicine and how collaboration will shape the future of fertility and reproductive health. Read about INNOVATE
Improving access to care and delivery to marginalized and vulnerable populations: a committee opinion (2025)
ASRM committee opinion on reducing infertility care disparities, outlining barriers and actionable strategies to improve equitable access. View the opinion
Key Abstracts Presented at the ASRM 2025 Scientific Congress & Expo
ASRM 2025 reveals support for IVF access, wildfire smoke's fertility risks, and how insurance mandates improve outcomes in reproductive health care. View the Press Release
American Society for Reproductive Medicine Reacts to White House Announcement on IVF Coverage
ASRM applauds the White House’s first steps toward IVF access but underscores that true equity demands mandatory insurance coverage. View the Press Release
ASRM Decries Latest Cuts at CDC
ASRM condemns sweeping staff cuts at CDC and HHS, warning they threaten reproductive and public health. View the Press Release
Preparing Experts in Reproductive Medicine to Engage Decisionmakers
ASRM’s PRIMED program trains reproductive health experts to advocate for evidence-based policy, empowering professionals to engage lawmakers and advance care access. ASRM PRIMED Program continues mission
Reproductive Medicine in the Era of Social Media: Pearls and Pitfalls
For couples struggling to conceive, social media has become a lifeline, a source of information, inspiration, and community. View the Latest Tech Talk post
Assisted Reproductive Technology (ART) Oversight: Lessons for the United States from Abroad
A comprehensive analysis of global Assisted Reproductive Technology (ART) regulations, comparing policies, accessibility, and ethical considerations in various countries. View the advocacy resource
ASRM Announces FY25 Patient Advocacy Grant Awardees
Congratulations to the Newest Grant Recipients! View more information about the patient advocacy grant
Opposition Rebuttal
ASRM's "Opposition Rebuttal" fact sheet counters common arguments against assisted reproductive technologies, offering evidence-based support for ART practices. View the advocacy points
Oversight of IVF in the US
In the US, medical care is regulated by a complex and comprehensive network of federal and state regulations and professional oversight. View the advocacy resource
What support for IVF looks like
Bipartisan support for IVF, that is responsible for the birth of over 2% of all babies born in the USA each year, will ensure that families continue to grow. View the advocacy resource
It takes more than one
Why IVF patients often need multiple embryos to have a baby View the advocacy resource
Ethical considerations for telemedical delivery of fertility care: an Ethics Committee opinion (2024)
Telemedicine has the potential to increase access to and decrease the cost of care. View the Committee Opinion
Cross-border reproductive care: an Ethics Committee opinion (2022)
Cross-border reproductive care is a growing worldwide phenomenon, raising questions about why assisted reproductive technology patients travel for care. View the Ethics Committee Document
Reproductive and infertility care in times of public health crises: an Ethics Committee opinion (2022)
Public health crises often require a framework shift in which patient autonomy is balanced with the need to safeguard the health of the community. View the Committee opinion
Access to fertility treatment irrespective of marital status, sexual orientation, or gender identity: an Ethics Committee opinion (2021)
Individuals and couples should have access to fertility services irrespective of marital status, sexual orientation, or gender identity. View the Committee Opinion
Disparities in access to effective treatment for infertility in the United States: an Ethics Committee opinion (2021)
In the United States, economic, racial, ethnic, geographic, and other disparities prevent access to fertility treatment and affect treatment outcomes. View the Committee Opinion
Exploring Access to Care for Marginalized Communities Course
Enhance your skills and contribute to reducing healthcare disparities for marginalized communities. Learn more about the Exploring Access to Care for Marginalized Communities Course
Access to Care Special Interest Group (ATCSIG)
The Access To Care Special Interest Group's purpose is to foster the growth of knowledge among the ASRM membership and the medical community regarding the unmet needs that exist today in access to reproductive care Learn more about the Special Interest Group
Patient Advocacy Grant
The ASRM Patient Advocacy Grants Program awards funds to patient advocacy organizations to support advocacy efforts and educational programs for patients. View more information about the patient advocacy grantTopic Resources
View more on the topic of assisted reproductive technologies
ASRM Physician Members Warn State Reporting Bills Could Turn Fertility Care Into a Political Target
ASRM warns state IVF reporting bills could threaten patient privacy, fertility care, and access by replacing medical expertise with political oversight. View the Press Release
Fertility and Sterility On Air - TOC: July 2026
Fertility and Sterility On Air covers latest reproductive medicine research, journal highlights, AI sperm detection, ART studies, and expert discussion roundup. Listen to the Episode
Policy Update from the ASRM Office of Public Affairs: SART Membership Now Mandatory in Tennessee
ASRM-backed Tennessee law makes SART membership mandatory for ART clinic certification, strengthening fertility care standards and oversight. View the Policy Update on Tennessee law
Fertility and Sterility On Air - Roundtable: In Vitro Gametogenesis
This week, we welcome Dr. Paula Amato and Professor Glenn Cohen to discuss the legal and ethical implications of in vitro gametogenesis (IVG). Listen to the Episode
ASRM Center for Policy and Leadership Releases Policy Report on Gestational Carrier Pregnancies
ASRM Center for Policy and Leadership released a report discussing gestational carrier policy in the U.S. discussing it's impact and how lawmakers should proceed going forward. View the Press Release
ASRM PRIMED scholar Dr. Caiyun Liao Publishes Article on RRM in JAMA
A new Viewpoint warns about the growing politicization and promotion of “restorative reproductive medicine." View the Press Release
ASRM Ethics and Practice Committees Release New Report Concluding Polygenic Embryo Screening Is Not Ready for Clinical Use
New analysis finds that PGT-P lacks proven clinical utility and raises significant scientific and ethical concerns. View the Press Release
Unlocking the Future of IVF: Navigating the Complex World of IVF Genomics
Explore the rise of IVF genomics, from PGT-A to WGS and polygenic risk scores, with insights on ethics, costs, and future implications for embryo screening. Read the Blog post
Assisted reproduction with advancing paternal and maternal age: an Ethics Committee opinion (2025)
Explore ethical considerations in assisted reproduction for older parents, balancing reproductive autonomy with potential offspring well-being. View the Committee Opinion
Code O09.01 vs O09.811 for Pregnancy Patients
Is code O09.01 acceptable for all pregnancy patients, or for same-sex cases View the Answer
Disclosure of medical errors and untoward events involving gametes and embryos: an Ethics Committee opinion (2024)
Medical providers have an ethical duty to disclose clinically significant errors involving gametes and embryos. View the Committee Opinion
Use of preimplantation genetic testing for monogenic adult-onset conditions: an Ethics Committee opinion (2024)
Preimplantation genetic testing for adult-onset monogenic diseases is ethically allowed when fully penetrant or conferring disease predisposition. View the Committee Opinion
When to use code Z31.83
When a patient is completing an approved fertility cycle, is it necessary View the Answer
Timed Intercourse Cycle Codes
Is it appropriate to utilize codes N97.8 or View the Answer
Billing Physician vs Service Physician
What physician’s name must be on the treatment notes and who we are permitted to bill to insurance for: View the Answer
Journal Club Global: Falha de implantação: realidade ou ilusão estatística?
Fertility and Sterility Global Journal Club from Brazil View the Video
The use of hormonal contraceptives in fertility treatments: a committee opinion (2024)
Hormonal contraception aids in the timing of ART cycles, reduce ovarian cysts at IVF cycle initiation, and optimize visualization before hysteroscopy. View the Committee Opinion
Opposition Rebuttal
ASRM's "Opposition Rebuttal" fact sheet counters common arguments against assisted reproductive technologies, offering evidence-based support for ART practices. View the advocacy points
Family members as gamete donors or gestational carriers: an Ethics Committee opinion (2024)
The use of adult intrafamilial gamete donors and gestational surrogates is ethically acceptable when all participants are fully informed and counseled. View the Committee Document
Semen analysis and thaw code
Can we use the semen analysis presence and motility (89300) code along with a reproductive tissue thaw code (89354) View the Answer
Billing for assisted hatching at biopsy and transfer
We would also like to know if you can bill assisted hatching with biopsy and then assisted hatching again during the transfer cycle. View the Answer
Diagnosis code for donation
What is the diagnosis code for an embryo donation versus egg donation? View the Answer
Coding for an endometrial biopsy/Mock cycle
We had patients request us to bill their insurance for the two monitoring visits and the Endo BX and change the diagnosis code to something that is payable. View the Answer
Financial ‘‘risk-sharing’’ or refund programs in assisted reproduction: an Ethics Committee opinion (2023)
Financial ‘‘risk-sharing’’ fee structures in programs charge patients a higher initial fee but provide reduced fees for subsequent cycles. View the Committee Document
Prevention of moderate and severe ovarian hyperstimulation syndrome: a guideline (2023)
Ovarian hyperstimulation syndrome is a serious complication associated with assisted reproductive technology. View the guideline
Guidance for coding limited or follow-up ultrasounds used during an IVF Cycle
I am a coder for a Reproductive Endocrinologist's office and am looking for some guidelines on limited or follow-up ultrasounds used during an IVF Cycle. View the Answer
Billing for cryopreservation procedures on different days
I understand that if cryopreservation of oocytes is performed on two separate dates of service, each date of service was billable. View the Answer
Measurements to report with ultrasound codes
Are there clear guidelines as to what measurements are required in order to bill for each type of ultrasound? VIew the Answer
Billing IVF lab work
We typically bill our IVF Lab work under the rendering provider who performs the VOR. Who should be the supervising provider for embryology billing? View the Answer
Estradiol Free versus Total
Should patients with fertility issues be billing Estradiol Free (82681) instead of Estradiol Total (82670)? View the Answer
IVF coverage denied for Z31.83 diagnosis code
My wife and I have been seeking IVF treatment and coverage was added for infertility treatment (up to $25,000) but our insurer keeps denying it. View the Answer
Cycle coordination fees and 99499, S4042
I reviewed cycle coordination fees, but see that there is no specific code for cycle management. View the Answer
Supervising provider for embryology billing
We typically bill our IVF Lab work under the rendering provider who performs the VOR. Who should be the supervising provider for embryology billing? View the Answer
Journal Club Global - Revisiting the STAR trial: The Fellows debate PGT-A
We are excited to host a debate covering the pros and cons of PGT-A and how new technologies should be validated before clinical implementation. View the Video
Informed consent in assisted reproduction: an Ethics Committee opinion (2023)
Informed consent is a process in which the patient is supported in developing an understanding of medical options. View the Ethics Committee Opinion
Unlisted Fertility Treatment CPT Code
Can you please refer me to an unlisted management CPT code for fertility treatment? View the Answer
Z Codes Vs. Procedure Codes For Fertility Preservation Counseling
I am trying to understand better when to use the procreative management code vs the fertility preservation counseling and procedure codes. View the Answer
Pregnancy Of Unknown Location
What is the most appropriate ICD-10 code for pregnancy of unknown location (not an ectopic pregnancy)? View the Answer
Pregnancy Ultrasound
Our practice does routine ultrasounds (sac check- 76817) at the end of an IVF cycle and bill with a diagnosis code O09.081, pregnancy resulting from ART. View the Answer
In Vitro Maturation
Have CPT codes been established for maturation in vitro? View the Answer
IUI Same Gender
When managing an IUI or IVF cycle for a female same sex couple or a patient that has no exposure to sperm, what ICD 10 diagnosis should be used? View the Answer
Limited Monitoring Ultrasound
What is the appropriate code to use for a limited follow-up follicular transvaginal ultrasound? View the Answer
Limited Transvaginal Ultrasound
One of our clients received information that a repeat limited transvaginal ultrasound should be billed with a limited pelvic ultrasound code (76857). View the Answer
Monitoring E&M
Our group would like to know if others are billing an evaluation and management code for ultrasound and blood draw visits? View the Answer
Monitoring FET
What is the correct diagnosis code to use on the follicle ultrasound (76857) for a patient who is undergoing frozen embryo transfer (FET)? View the Answer
Monitoring Ovulation Induction By Nurses
We are considering the use of CPT code 99211 for encounters during cycle management as part of ovulation induction. View the Answer
Non-REI Board Certified MD Performing REI Procedures
My boss has a few follow up questions about a non-REI board certified MD performing REI procedures. View the Answer
IVF Case Rates
What ICD-10 codes apply to case rates? View the Answer
Embryo Storage Fees For Multiple Cycles
We bill embryo storage 89342 for a year's storage. View the Answer
Endometrial Receptivity Analysis
Our physicians are going to start doing an Endometrial Receptivity Analysis. Do you know the appropriate CPT code that should be used?View the Answer
Flat Fee For Outside Monitoring
Can our office charge outside monitoring patients a flat fee to be seen? View the Answer
Diagnosis Code For Same-Sex Egg Donation
We have a same-sex male couple with insurance coverage for IVF. View the Answer
Donor Embryos
Could you give guidance for the correct ICD-10 code(s) to use when a patient is doing an Anonymous Donor Embryo Transfer cycle? View the Answer
Assisted Hatching Billed With Embryo Biopsy
Do you know if both assisted hatching (89253) and embryo biopsy for PGS/PGD/CCS (89290/89291) can be billed during the same cycle? View the Answer
Billing at an Outside Clinic for Lab Services
One of my physicians uses an outside facility to perform the retrievals and transfers. View the Answer
Coding For Placement Of A Cervical Stitch
Physicians at our practice are placing a stitch and dilating the cervix after egg retrievals for those patients that have cervical stenosis. View the Answer
Board Certified Vs. Non-Board Certified Billing
Is coding/billing any different when a non-board certified or non-REI provider submits for REI procedure? View the Answer
Mental-health Services During Assisted Reproduction
A summary of codes for Mental-health Services During Assisted Reproduction compiled by the ASRM Coding Committee. View the Coding Summary
Laboratory Procedures during ART Cycles
A listing of codes, compiled for a fresh ART cycle, transfer, biopsy, cryopreservation of embryos and oocytes, storage, and thawing. View the Coding Summary
Journal Club Global: Evidence for Immunologic Therapies in Women Undergoing ART
Reproductive immunology is perhaps one of the most controversial and promising fields within ART. View the Video
Comprehensive guidance for human embryology, andrology, and endocrinology laboratories: management and operations: a committee opinion (2022)
ASRM has published guidance and minimum standards for embryology and andrology laboratories. View the Committee Opinion
Journal Club Global - Best Practices of High Performing ART Clinics
This Fertility and Sterility Journal Club Global discusses February’s seminal article, “Common practices among consistently high-performing in vitro fertilization programs in the United States: a 10 year update.” View the Video
Journal Club Global - Fertilization rate as a novel indicator in ART results
This Journal Club Global discusses a provocative article recently published in Fertility and Sterility, discussing the results of a multicenter retrospective cohort study with the objective to appraise the fertilization rate as a predictive factor for cumulative live birth rate (CLBR). View the Video
Journal Club Global - Are We Approaching Automation in ART?
Some ART diagnostic devices are already available and offer objective tools of evaluation. View the Video
Guidance on the limits to the number of embryos to transfer: a committee opinion (2021)
ASRM's guidelines for the limits on the number of embryos to be transferred during IVF cycles have been further refined ... View the Committee Opinion
Role of tubal surgery in the era of assisted reproductive technology: a committee opinion (2021)
This document reviews surgical options for reparative tubal surgery and the factors that must be considered when deciding between surgical repair and IVF.View the Committee Opinion
Minimum standards for practices offering assisted reproductive technologies: a committee opinion (2021)
A framework for assisted reproductive technology (ART) programs that meet or exceed the requirements suggested by the Centers for Disease Control View the Committee Opinion
Journal Club Global - Recurrent Implantation Failures in ART: Myth or Reality?
Classically, implantation failures in ART were believed to result from alterations in embryo or endometrium quality.
View the Video
The role of immunotherapy in in vitro fertilization: a guideline (2018)
ASRM guideline evaluates current evidence on immunotherapy use in IVF, finding limited support for routine adjuvant immunomodulating treatments. View the Committee Opinion
Recommended practices for the management of embryology, andrology, and endocrinology laboratories: a committee opinion (2014)
A general overview for good management practices within the endocrinology, andrology, and embryology laboratories in the United States. View the Recommendation
